1. Home
  2. NOTV vs CNF Comparison

NOTV vs CNF Comparison

Compare NOTV & CNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • CNF
  • Stock Information
  • Founded
  • NOTV 1974
  • CNF 1999
  • Country
  • NOTV United States
  • CNF China
  • Employees
  • NOTV N/A
  • CNF N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • CNF Finance: Consumer Services
  • Sector
  • NOTV Health Care
  • CNF Finance
  • Exchange
  • NOTV Nasdaq
  • CNF Nasdaq
  • Market Cap
  • NOTV 95.2M
  • CNF 89.2M
  • IPO Year
  • NOTV 1997
  • CNF 2018
  • Fundamental
  • Price
  • NOTV $3.94
  • CNF $0.89
  • Analyst Decision
  • NOTV Strong Buy
  • CNF
  • Analyst Count
  • NOTV 3
  • CNF 0
  • Target Price
  • NOTV $5.92
  • CNF N/A
  • AVG Volume (30 Days)
  • NOTV 1.2M
  • CNF 44.7K
  • Earning Date
  • NOTV 02-05-2025
  • CNF 12-24-2024
  • Dividend Yield
  • NOTV N/A
  • CNF N/A
  • EPS Growth
  • NOTV N/A
  • CNF N/A
  • EPS
  • NOTV N/A
  • CNF 0.24
  • Revenue
  • NOTV $490,739,000.00
  • CNF $109,788,152.00
  • Revenue This Year
  • NOTV $7.14
  • CNF N/A
  • Revenue Next Year
  • NOTV $5.73
  • CNF $13.09
  • P/E Ratio
  • NOTV N/A
  • CNF $4.00
  • Revenue Growth
  • NOTV N/A
  • CNF 12.99
  • 52 Week Low
  • NOTV $1.23
  • CNF $0.81
  • 52 Week High
  • NOTV $11.42
  • CNF $2.84
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 53.75
  • CNF 39.78
  • Support Level
  • NOTV $4.63
  • CNF $0.81
  • Resistance Level
  • NOTV $6.48
  • CNF $0.95
  • Average True Range (ATR)
  • NOTV 0.73
  • CNF 0.07
  • MACD
  • NOTV 0.05
  • CNF 0.01
  • Stochastic Oscillator
  • NOTV 30.33
  • CNF 25.93

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.

About CNF CNFinance Holdings Limited each representing twenty (20)

CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, it has an operation in PRC.

Share on Social Networks: